Pfizer's Q2 Revenue and Earnings Beat Expectations, as Sales of Pfizer's COVID Antiviral Pill Surpass Estimates

  • 3 months ago
Pfizer's second-quarter revenue and adjusted earnings per share both exceeded analyst estimates, showing a growth from the previous year. Pfizer raised its full-year revenue and adjusted EPS guidance, reflecting increased expectations from earlier projections. Sales of the company's COVID antiviral pill, Paxlovid, increased year over year, beating estimates. Demand has increased in international markets. The company is focusing on cancer treatments following its acquisition of Seagen last year.
Transcript
00:00It's Benzinga, and here's what's on the block.
00:02Pfizer's second quarter revenue and adjusted earnings per share both exceeded analysts'
00:06estimates showing a growth from the previous year.
00:09Pfizer raised its full-year revenue and adjusted EPS guidance reflecting increased expectations
00:15from earlier projections.
00:17Sales of the company's COVID antiviral pill Paxlovid increased year-over-year, beating
00:21estimates.
00:22Demand has increased in international markets.
00:25The company is focusing on cancer treatments following its acquisition of CGen last year.
00:29To see all things money, visit Benzinga.com.

Recommended

0:35
I
Up next
Morgan Stanley Beats Q3 Estimates, Profits Surge More Than 30%
Benzinga
0:41
Venture Capital Funding For Generative AI Startups Account For 40% Of All Cloud Funding
Benzinga
0:39
ASML Shares Drop 16% After Releasing Weak Sales Forecast
Benzinga
0:43
GM Partners With Lithium Americas In $625 Million Joint Venture To Develop Nevada Lithium Mine
Benzinga
0:46
Harris Proposes Medicare Funding for At-Home Care As Costs Outpace Inflation, Weighing On Families
Benzinga
0:36
U.S. Crude Oil Prices Slip Below $71 on Middle East Tensions Easing
Benzinga
0:38
Wells Fargo CEO Says US Consumer 'Extremely Resilient,' Sees Consumer Spending Rising Steadily
Benzinga
0:38
Amazon Web Services Invests $500 Million In Small Modular Nuclear Reactor To Power AI
Benzinga
3:18
SHOCKING: Khalistani Leader Pannun Exposes SFJ’s Links to Trudeau’s Office in CBC Interview| Watch
Oneindia
0:32
DoorDash Exceeds Revenue Expectations in Q2 Performance, Sees Surge in Total Orders
Benzinga
0:31
AMD Shares Rebound After Chipmaker Posts Q2 Beat, Guidance Tops Expectations: CEO Lisa Su Says AI Business Accelerating
Benzinga
0:32
Merck's Q2 Revenue Beats Expectations on Strong Keytruda and Treatment Sales
Benzinga
3:30
Watch| India's Supreme Court Unveils New Statue of Justice: Open Eyes and Constitution in Hand
Oneindia
3:25
The Kutch Story |Emami Agrotech Bleeds | Toxic Fumes Kill 5 Workers | WATCH
Oneindia
0:42
Pfizer's Share Price Falls After Disappointing Revenue Forecast
Benzinga
0:45
Salesforce Beats Earnings and Revenue Expectations
Benzinga
0:38
Eli Lilly's Earnings Soar as Diabetes and Weight Loss Drugs Fuel Blockbuster Quarter
Benzinga
0:43
Procter & Gamble Beats Q1 Earnings Estimates
Benzinga
0:48
Activist Investor Starboard Takes $1 Billion Stake In Pfizer As The Pharmaceutical Faces Criticism Over Costly Acquisitions
Benzinga
0:41
British Fintech Zilch Achieves First-Ever Monthly Profit, Fast-Tracks Toward IPO After Doubling Revenue in Competitive Buy Now, Pay Later Market
Benzinga
0:35
CVS Health's Q2 Earnings Exceed Expectations, But Slash Full-Year Profit Forecast Due to Higher Medical Costs
Benzinga
0:40
Global Chipmakers Rise as Micron's Strong Revenue Forecast Spurs Global Chip Stock Rally
Benzinga
0:35
Novo Nordisk Raises Sales Growth Outlook Despite Profit Miss. CEO Predicts 'Attractive Growth' Amidst Competition and Regulation Shifts.
Benzinga
0:35
Apple and Nvidia Drive TSMC's Revenue Growth, Surpasses Analyst Forecasts with Over 30% Revenue Growth in Q2
Benzinga
0:46
Coca-Cola Beats Estimates with Strong Quarterly Earnings and Revenue
Benzinga